Fannie Wurtz, Managing Director at Amundi ETF, Indexing & Smart Beta, commented:

“2017 has been a record year for Amundi ETF, powered by our ability to deliver solutions for both retail and institutional client segments, which are growing significantly. Amundi ETF offers one of the most consistent and cost-competitive ranges of products, which are fast becoming essential asset allocation tools for investors of all stripes.

As investors grapple with a number of challenges in 2018, there has never been a greater need to respond to the specific requirements of clients, which we continuously address with product innovation and the development of competitive ETF-based solutions, leveraging our proximity with clients on the ground in Europe and Asia.”

Further information about Amundi ETF can be found on the amundietf.com website.

This document is intended solely for journalists and media professionals. The information about the Amundi ETF funds is provided solely to enable journalists and media professionals to have an overview of these funds, and whatever use they make, which is exclusively for independent editorial, Amundi Asset Management assumes no responsibility.

1.Source: Amundi ETF, Indexing & Smart Beta as at end 2017 - Excluding joint venture figures
2. At launch date on Euronext Paris - For further information on the index methodology please refer to https://www.stoxx.com/indices
3.  At launch date on Borsa Italiana - For further information on the index methodology please refer to the index provider website http://www.ftserussell.com/

Important information

This document is not intended for use by residents or citizens of the United States of America and “U.S. Persons” as defined by Regulation S of the Securities and Exchange Commission by virtue of the U.S. Securities Act of 1933. You can find the definition of “U.S. Person” in the legal notices of the website: www.amundi.com website and in the prospectus of the fund described in this document.

Promotional, non-contractual information not constituting investment advice or recommendation or solicitation to buy or sell.

Before subscribing, potential investors must consult the regulatory documentation of the Funds approved by the AMF, including the current Key Investor Information Document (KIID) available on the website www.amundi.com or upon request from the registered office of Amundi AM.

Investment in a Fund carries a substantial degree of risk (i.e. risks are detailed in the DICI and prospectus).

The transparency policy and information on the composition of Funds’ assets is available at amundietf.com. The indicative net asset value is published by stockbrokers. Information on the composition of indices is available on the websites of the index suppliers. Units in the Funds acquired on the secondary market may not, in general terms, be directly resold to the Fund.

Investors must buy and sell units on a secondary market with the assistance of an intermediary (e.g. a broker) and, in doing so, may incur costs. In addition, investors may pay more than the current net asset value when they buy units, and may receive less than the current net asset value when they sell them.

Transaction cost and commissions may occur  when trading ETFs.

It is the responsibility of investors to assure themselves as to the compatibility of this investment with the laws of the jurisdiction to which they are subject and of its appropriateness to their investment objectives and financial (including tax) situation.

Information reputed exact as of January 2018.

Reproduction prohibited without the written consent of the Management Company.

Amundi ETF designates the ETF business of Amundi Asset Management.

This Document was not reviewed/stamped/approved by any Financial Authority;

Disclaimer UK

The following funds mentioned in the document are recognized collective investment schemes under s.264 of the United Kingdom Financial Services and Markets ACT 2000: AMUNDI ETF FLOATING RATE USD CORPORATE UCITS ETF, AMUNDI ETF MSCI EMERGING MARKETS UCITS ETF and AMUNDI ETF ISTOXX EUROPE MULTI-FACTOR MARKET NEUTRAL UCITS ETF.

However, AMUNDI ETF FTSE ITALIA PIR UCITS ETF DR is an unregulated collective investment scheme for purposes of the UK Financial Services and Markets Act 2000 (“FSMA”) and, as such, information on this fund must not be provided to retail clients in the UK

This document is being issued in the United Kingdom by Amundi Asset Management  which is authorized by the Autorité des Marchés Financiers and subject to limited regulation by the Financial Conduct Authority for the conduct of investment business in the United Kingdom under number 401883 with its registered office at 41 Lothbury, London EC2R 7HF. Details about the extent of regulation by the FCA are available on request. This document is only directed at persons who are professional clients or eligible counterparties for the purposes of the FCA’s Conduct of Business Sourcebook. The investments described herein are only available to such persons and this document must not be relied or acted upon by any other persons. This document may not be distributed to any person other than the person to whom it is addressed without the express prior consent of Amundi.

Disclaimer MARKIT iBOXX

The Markit iBoxx® brand and indices are the intellectual property of International Index Company Limited. A license has been granted to Amundi to use them for certain purposes. Markit iBoxx® indices are the property of International Index Company Limited and are used under license. The fund is neither approved, nor sponsored or recommended by International Index Company Limited. Markit iBoxx® indices are trademarks of International Index Company Limited -“the index sponsor”- and used under license for the funds mentioned in the document.

Disclaimer MSCI

The funds are not sponsored, endorsed, sold or promoted by Morgan Stanley Capital International Inc. (“MSCI”), any of its affiliates, any of its information providers or any other third party involved in, or related to, compiling, computing or creating any MSCI index (collectively, the “MSCI parties”). The MSCI indexes are the exclusive property of MSCI. MSCI and the MSCI index names are service mark(s) of MSCI or its affiliates and have been licensed for use for certain purposes by Amundi AM. None of the MSCI parties makes any representation or warranty, express or implied, to the issuer or owners of this fund or any other person or entity regarding the advisability of investing in funds generally or in this fund particularly or the ability of any MSCI index to track corresponding stock market performance. A complete description of the MSCI indexes is available on request from MSCI. MSCI indexes are registered trademark of MSCI which are used to identify indexes it calculates and publishes.

MSCI guarantees neither the value of the index at any given time nor the results or performance of products indexed against this index.

Disclaimer Scientific Beta Index

The Scientific Beta index is the intellectual property (including registered trademarks) of EDHEC Risk Institute Asia Ltd and/or its licensors, which is used under license within the framework of ERI Scientific Beta activity. The fund is not sponsored, endorsed or sold by EDHEC Risk Institute Asia Ltd and its licensors and neither its licensors shall have any liability with respect thereto.

Disclaimer STOXX

The iSTOXX Europe Multi-Factor Market Neutral  index is the intellectual property (including registered trademarks) of STOXX Limited, Zurich, Switzerland and/or its licensors (“Licensors”), which is used under license. The securities based on the Index are in no way sponsored, endorsed, sold or promoted by STOXX and its Licensors and neither of the Licensors shall have any liability with respect thereto.

Disclaimer FTSE

This fund is not in any way sponsored, endorsed, sold or promoted by FTSE International Limited (“FTSE”), The London Stock Exchange Plc, The Financial Times Limited, SPH Data Services Pte Ltd or Singapore Press Holdings Ltd (together, “SPH”) or Singapore Exchange Securities Trading Limited (“SGX”) (collectively hereinafter referred to as the “Index Sponsor”). The Index Sponsor makes no warranty or representation whatsoever, either expressly or impliedly, either as to the results to be obtained from the “Index” and / or the figure at which the Index stands at any particular time on any particular day or otherwise. The Index Sponsor further does not warrant nor represent nor guarantee to any broker or holder of any Securities sold or marketed by Amundi AM or any member of the public as to the accuracy or completeness of the Index and its computation or any information related thereto. No warranty or representation or guarantee of any kind whatsoever relating to the Index or the Securities is given by the Index Sponsor. The Securities are not issued, endorsed, sold or promoted by the Index Sponsor and the Index Sponsor bears no liability in connection with the administration, marketing or trading of the Securities. The Index is calculated by FTSE. The Index Sponsor accepts no liability (whether in negligence or otherwise) towards any person for any error in the Index and shall not be under any obligation to advise any person of any error therein. The compilation or composition of the Index or the constituent stocks and factors may be altered or changed by the Index Sponsor without notice. The Index Sponsor is entitled to all relevant intellectual property rights in the Index. This document is of a commercial and not of a regulatory nature.